Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma

Acta Neuropathologica

Volumn 122, Issue 4, 2011, Pages 495-510

  Svendsen, Agnete ^a   Verhoeff, Joost J C ^b   Immervoll, Heike ^c   Brøgger, Jan C ^c   Kmiecik, Justyna ^a   Poli, Aurelie ^a,c   Netland, Inger A ^a   Prestegarden, Lars ^c   Planagumà, Jesús ^a   Torsvik, Anja ^a   Kjersem, Anneli Bohne ^d   Sakariassen, Per O ^a   Heggdal, Jan I ^b   Van Furth, Wouter R ^b   Bjerkvig, Rolf ^a,c   Lund Johansen, Morten ^c   Enger, Per O ^a,c   Felsberg, Joerg ^e   Brons, Nicolaas H C ^c   Tronstad, Karl J ^a   Waha, Andreas ^f   Chekenya, Martha ^a,g   more..

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d DNV GL   (Norway)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL BONN   (Germany)

^g Translational Cancer Research Group   (Norway)

Author keywords

CD133, DNA damage; Glioblastoma; NG2; Peroxiredoxin 1; Radiation resistance

Indexed keywords

ANTINEOPLASTIC AGENT; CD133 ANTIGEN; NESTIN; NEURON GLIAL 2 PROTEIN; PEROXIREDOXIN 1; PROCARBAZINE; TEMOZOLOMIDE; UNCLASSIFIED DRUG; VIMENTIN; VINCRISTINE;

ADULT; AGE; ARTICLE; BRAIN BIOPSY; BRAIN RADIATION; BRAIN SURGERY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL CYCLE PROGRESSION; CONTROLLED STUDY; CSPG4 GENE; DNA DAMAGE; DNA METHYLATION; GAMMA KNIFE RADIOSURGERY; GENE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IN VIVO STUDY; IONIZING RADIATION; MAJOR CLINICAL STUDY; MGMT GENE; OXIDATIVE STRESS; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOSENSITIVITY; RADIOSENSITIZATION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR VASCULARIZATION; UPREGULATION;

AGED; ANTIGENS; BRAIN NEOPLASMS; DNA DAMAGE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEOGLYCANS; RADIATION TOLERANCE; RADIATION, IONIZING; STEM CELLS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84860392773     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-011-0867-2     Document Type: Article

References (52)

1. S Bao Q Wu RE McLendon, et al. 2006 Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 756 760 17051156 10.1038/nature05236 1:CAS:528:DC%2BD28Xht1OntbzP (Pubitemid 44949604)
2. FG Behm FO Smith SC Raimondi CH Pui ID Bernstein 1996 Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements Blood 87 1134 1139 8562939 1:CAS:528:DyaK28XnsFGmtA%3D%3D
3. S Belachew R Chittajallu AA Aguirre, et al. 2003 Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons J Cell Biol 161 169 186 12682089 10.1083/jcb.200210110 1:CAS:528:DC%2BD3sXjtVait7c%3D (Pubitemid 36459089)
4. MS Benassi L Pazzaglia A Chiechi, et al. 2009 NG2 expression predicts the metastasis formation in soft-tissue sarcoma patients J Orthop Res 27 135 140 18634019 10.1002/jor.20694
5. C Brekke A Lundervold PO Enger, et al. 2006 NG2 expression regulates vascular morphology and function in human brain tumours Neuroimage 29 965 976 16253523 10.1016/j.neuroimage.2005.08.026 1:STN:280:DC%2BD28%2FktlOgsQ%3D%3D (Pubitemid 43121220)
6. B Campos F Wan M Farhadi, et al. 2010 Differentiation therapy exerts antitumor effects on stem-like glioma cells Clin Cancer Res 16 2715 2728 20442299 10.1158/1078-0432.CCR-09-1800 1:CAS:528:DC%2BC3cXlvF2iu7o%3D
7. HY Chang DS Nuyten JB Sneddon, et al. 2005 Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival Proc Natl Acad Sci USA 102 3738 3743 15701700 10.1073/pnas.0409462102 1:CAS:528:DC%2BD2MXisVOgtr4%3D (Pubitemid 40354681)
8. M Chekenya PO Enger F Thorsen, et al. 2002 The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours Neuropathol Appl Neurobiol 28 367 380 12366818 10.1046/j.1365-2990.2002.00412.x 1:CAS:528:DC%2BD38Xoslyit7k%3D (Pubitemid 35282452)
9. M Chekenya M Hjelstuen PO Enger, et al. 2002 NG2 proteoglycan promotes angiogenesis-dependent tumor growth in CNS by sequestering angiostatin Faseb J 16 586 588 11919162 1:CAS:528:DC%2BD38XivVOjtr8%3D
10. M Chekenya C Krakstad A Svendsen, et al. 2008 The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling Oncogene 27 5182 5194 18469852 10.1038/onc.2008.157 1:CAS:528:DC%2BD1cXhtVKrsL%2FN
11. M Chekenya HK Rooprai D Davies, et al. 1999 The NG2 chondroitin sulfate proteoglycan: role in malignant progression of human brain tumours Int J Dev Neurosci 17 421 435 10571405 10.1016/S0736-5748(99)00019-2 1:CAS:528: DC%2BD3cXhtlyqsA%3D%3D (Pubitemid 29421830)
12. MF Chen PC Keng H Shau, et al. 2006 Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression Int J Radiat Oncol Biol Phys 64 581 591 16414373 10.1016/j.ijrobp.2005.10.012 1:CAS:528:DC%2BD28Xls1Siuw%3D%3D (Pubitemid 43083448)
13. R Chen MC Nishimura SM Bumbaca, et al. 2010 A hierarchy of self-renewing tumor-initiating cell types in glioblastoma Cancer Cell 17 362 375 20385361 10.1016/j.ccr.2009.12.049 1:CAS:528:DC%2BC3cXmsF2msLY%3D
14. YM Chung YD Yoo JK Park YT Kim HJ Kim 2001 Increased expression of peroxiredoxin II confers resistance to cisplatin Anticancer Res 21 1129 1133 11396151 1:CAS:528:DC%2BD3MXksVOjt7k%3D
15. JP Conway M Kinter 2006 Dual role of peroxiredoxin I in macrophage-derived foam cells J Biol Chem 281 27991 28001 16880205 10.1074/jbc.M605026200 1:CAS:528:DC%2BD28XpsFOrtbo%3D (Pubitemid 44414512)
16. NA Franken HM Rodermond J Stap J Haveman C van Bree 2006 Clonogenic assay of cells in vitro Nat Protoc 1 2315 2319 17406473 10.1038/nprot.2006.339 1:CAS:528:DC%2BD2sXhtFGjtLnI
17. K Freier S Joos C Flechtenmacher, et al. 2003 Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma Cancer Res 63 1179 1182 12649172 1:CAS:528: DC%2BD3sXit1Sgt7s%3D (Pubitemid 36348691)
18. ME Hegi AC Diserens T Gorlia, et al. 2005 MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 997 1003 15758010 10.1056/NEJMoa043331 1:CAS:528:DC%2BD2MXit1Wktro%3D (Pubitemid 40349502)
19. M Hockel K Schlenger M Mitze U Schaffer P Vaupel 1996 Hypoxia and radiation response in human tumors Semin Radiat Oncol 6 3 9 10717157 10.1016/S1053-4296(96)80031-2 (Pubitemid 26029370)
20. H Ichijo E Nishida K Irie, et al. 1997 Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways Science 275 90 94 8974401 10.1126/science.275.5296.90 1:CAS:528:DyaK2sXjsFSmtQ%3D%3D (Pubitemid 27020316)
21. JH Kim PN Bogner N Ramnath, et al. 2007 Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer Clin Cancer Res 13 3875 3882 17606720 10.1158/1078-0432.CCR-06-2893 1:CAS:528:DC%2BD2sXntFymtrs%3D (Pubitemid 47037594)
22. YJ Kim JY Ahn P Liang, et al. 2007 Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology Cancer Res 67 546 554 17234762 10.1158/0008-5472.CAN-06-2401 1:CAS:528:DC%2BD2sXmtVKlug%3D%3D (Pubitemid 46192191)
23. VL Kinnula S Lehtonen R Sormunen, et al. 2002 Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma J Pathol 196 316 323 11857495 10.1002/path.1042 1:CAS:528:DC%2BD38XisVWltLw%3D (Pubitemid 34189421)
24. Kleihues P, Burger PC, Collins VP et al (2000) Glioblastoma. In: Kleihues P, Cavenee WK (eds) World Health Organisation classification of tumours. Pathology and genetics. Tumours of the central nervous system. IARC Press, Lyon, pp 29-39
25. Y Li MC Madigan K Lai, et al. 2003 Human uveal melanoma expresses NG2 immunoreactivity Br J Ophthalmol 87 629 632 12714409 10.1136/bjo.87.5.629 1:STN:280:DC%2BD3s3ht1Sqsw%3D%3D (Pubitemid 36535340)
26. Lieberman HB (2004) Cell cycle checkpoint control protocols. Humana Press, New York
27. DN Louis H Ohgaki OD Wiestler, et al. 2007 The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 97 109 17618441 10.1007/s00401-007-0243-4 (Pubitemid 47103521)
28. L Mauvieux E Delabesse P Bourquelot, et al. 1999 NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases Br J Haematol 107 674 676 10583275 10.1046/j.1365-2141.1999.01730.x 1:CAS:528:DC%2BD3cXhtlKgsA%3D%3D
29. RFA McLendon D Bigner EG Van Meir DJ Brat GM Mastrogianakis, et al. 2008 Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 455 1061 1068 10.1038/nature07385 1:CAS:528:DC%2BD1cXht1yju77J
30. T Mikeska C Bock O El-Maarri, et al. 2007 Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis J Mol Diagn 9 368 381 17591937 10.2353/jmoldx.2007.060167 1:CAS:528:DC%2BD2sXot1Kqsrc%3D (Pubitemid 47305073)
31. A Nishiyama KJ Dahlin JT Prince SR Johnstone WB Stallcup 1991 The primary structure of NG2, a novel membrane-spanning proteoglycan J Cell Biol 114 359 371 1906475 10.1083/jcb.114.2.359 1:CAS:528:DyaK38Xhs1ymsr8%3D (Pubitemid 21909807)
32. DY Noh SJ Ahn RA Lee, et al. 2001 Overexpression of peroxiredoxin in human breast cancer Anticancer Res 21 2085 2090 11497302 1:CAS:528: DC%2BD3MXmt1eqtro%3D
33. F Odreman M Vindigni ML Gonzales, et al. 2005 Proteomic studies on low- and high-grade human brain astrocytomas J Proteome Res 4 698 708 15952716 10.1021/pr0498180 1:CAS:528:DC%2BD2MXjs1Siu7k%3D (Pubitemid 40863258)
34. H Ohgaki P Kleihues 2005 Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas J Neuropathol Exp Neurol 64 479 489 15977639 1:CAS:528:DC%2BD2MXlvVSgsbg%3D (Pubitemid 40781150)
35. JH Park YS Kim HL Lee, et al. 2006 Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung Respirology 11 269 275 16635084 10.1111/j.1440-1843.2006.00849.x
36. SH Park YM Chung YS Lee, et al. 2000 Antisense of human peroxiredoxin II enhances radiation-induced cell death Clin Cancer Res 6 4915 4920 11156252 1:CAS:528:DC%2BD3MXotlersw%3D%3D
37. HS Phillips S Kharbanda R Chen, et al. 2006 Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis Cancer Cell 9 157 173 16530701 10.1016/j.ccr.2006.02.019 1:CAS:528:DC%2BD28XivFWjtL4%3D (Pubitemid 43357943)
38. L Prestegarden A Svendsen J Wang, et al. 2010 Glioma cell populations grouped by different cell type markers drive brain tumor growth Cancer Res 70 4274 4279 20460538 10.1158/0008-5472.CAN-09-3904 1:CAS:528:DC%2BC3cXmslWgsb4%3D
39. JR Requena MX Fu MU Ahmed, et al. 1996 Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions Nephrol Dial Transplant 11 Suppl 5 48 53 9044307 1:CAS:528:DyaK2sXhsFCitbo%3D (Pubitemid 27062911)
40. SG Rhee SW Kang TS Chang W Jeong K Kim 2001 Peroxiredoxin, a novel family of peroxidases IUBMB Life 52 35 41 11795591 10.1080/15216540252774748 1:CAS:528:DC%2BD38Xmt12ktg%3D%3D (Pubitemid 33769667)
41. PA Riley 1994 Free radicals in biology: oxidative stress and the effects of ionizing radiation Int J Radiat Biol 65 27 33 7905906 10.1080/ 09553009414550041 1:CAS:528:DyaK2cXitFWltrw%3D (Pubitemid 24063526)
42. P Roepstorff J Fohlman 1984 Proposal for a common nomenclature for sequence ions in mass spectra of peptides Biomed Mass Spectrom 11 601 6525415 10.1002/bms.1200111109 1:CAS:528:DyaL2MXlvVOgtg%3D%3D
43. M Schrappe FG Klier RC Spiro, et al. 1991 Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells Cancer Res 51 4986 4993 1893386 1:CAS:528:DyaK3MXlvVSmtrk%3D
44. Y Shoshan A Nishiyama A Chang, et al. 1999 Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors Proc Natl Acad Sci USA 96 10361 10366 10468613 10.1073/pnas.96.18.10361 1:CAS:528:DyaK1MXlvFentrY%3D (Pubitemid 29422563)
45. FO Smith C Rauch DE Williams, et al. 1996 The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23 Blood 87 1123 1133 8562938 1:CAS:528:DyaK28XnsFGmtw%3D%3D
46. PS Smith-Pearson M Kooshki DR Spitz, et al. 2008 Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2) Free Radic Biol Med 45 8 1178 1189 18718523 10.1016/j.freeradbiomed.2008.07.015 1:CAS:528: DC%2BD1cXht1SiurrO
47. AM Snijders N Nowak R Segraves, et al. 2001 Assembly of microarrays for genome-wide measurement of DNA copy number Nat Genet 29 263 264 11687795 10.1038/ng754 1:CAS:528:DC%2BD3MXotlWhsLs%3D (Pubitemid 33096449)
48. DR Spitz JW Phillips DT Adams, et al. 1993 Cellular resistance to oxidative stress is accompanied by resistance to cisplatin: the significance of increased catalase activity and total glutathione in hydrogen peroxide-resistant fibroblasts J Cell Physiol 156 72 79 8314861 10.1002/jcp.1041560111 1:CAS:528:DyaK3sXltVymtL4%3D (Pubitemid 23211264)
49. R Stupp WP Mason MJ van den Bent, et al. 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987 996 15758009 10.1056/NEJMoa043330 1:CAS:528:DC%2BD2MXit1Wksbk%3D (Pubitemid 40349501)
50. JJ Verhoeff LJ Stalpers AW Coumou, et al. 2007 Experimental iodine-125 seed irradiation of intracerebral brain tumors in nude mice Radiat Oncol 2 38 17897452 10.1186/1748-717X-2-38
51. J Wang A Svendsen J Kmiecik, et al. 2011 Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma PLoS One 6 7 e23062 21829586 10.1371/journal.pone.0023062 1:CAS:528:DC%2BC3MXhtVyksbfO
52. B Zhang Y Wang K Liu, et al. 2008 Adenovirus-mediated transfer of siRNA against peroxiredoxin I enhances the radiosensitivity of human intestinal cancer Biochem Pharmacol 75 660 667 17976536 10.1016/j.bcp.2007.09.016 1:CAS:528:DC%2BD1cXlvVOhug%3D%3D